Study | Data for studies reporting urogenital CT testing | Data for studies reporting a history of AI | Additional information | ||||||||
Women, n (%) | Women, n (%) | ||||||||||
Rectal CT-positive and urogenital CT-positive | Rectal CT-negative and urogenital CT-positive | Rectal CT-positive and urogenital CT-negative | Rectal CT-positive and urogenital CT-negative | Total | Rectal CT-positive and AI reported | Rectal CT-negative and AI reported | Rectal CT-positive and no AI reported | Rectal CT-negative and no AI reported | Total | ||
A | B | C | D | E | F | G | H | I | J | ||
Bachmann et al 7 | 20 (23.8) | 3 (3.6) | 7 (8.3) | 54 (64.3) | 84 | 9 (9.0) | 30 (30.0) | 25 (25.0) | 36 (36.0) | 100 | High-risk settings (STD clinic and three HIV clinics) and women tested if were at high risk or had a history of AI |
Bazan et al 8 | 38 (11.4) | 5 (1.5) | 6 (1.8) | 285 (85.3) | 334 | 46 (13.5) | 295 (86.5) | NA | NA | 341 | All women reported a history of AI. |
Cosentino et al 26 | 21 (7.7) | 251 (92.3) | NA | NA | 272 | No data were reported for urogenital CT infections. All women reported a history of AI. | |||||
Ding and Challenor9 | 97 (81.5) | 22 (18.5) | NA | NA | 119 | 20 (20.6) | 5 (5.2) | 55 (56.7) | 17 (17.5) | 97 | All women were positive for a urogenital CT infection. |
Garner et al 29 | 6 (6.6) | 85 (93.4) | NA | NA | 91 | All women reported a history of AI. | |||||
Gratrix et al 17 | 224 (7.3) | 76 (2.5) | 132 (4.3) | 2622 (85.9) | 3054 | 48 (13.0) | 13 (3.5) | 308 (83.5) | Number of women who had a negative rectal CT test and did not report a history of AI is unknown from the data reported. | ||
Hunte et al 27 | 16 (16.5) | 0 | 1 (1.0) | 80 (82.5) | 97 | 17 (17.5) | 80 (82.5) | NA | NA | 97 | All women reported a history of AI. |
Mayer et al 30 | There are no data on urogenital CT collected and no data on history of AI collected. All women were HIV-positive. | ||||||||||
Musil et al 33 | 31 (55.4) | 7 (12.5) | 1 (1.8) | 17 (30.4) | 56 | 17 (30.4) | 17 (30.4) | 15 (26.8) | 7 (12.5) | 56 | Women at high risk of infection (had symptoms, follow-up, sexual contact with a positive case) |
Ostergaard et al 34 | 9 (4.6) | 11 (5.6) | 2 (1.0) | 174 (88.8) | 196 | 4 (2.0) | 82 (41.8) | 7 (3.6) | 103 (52.6) | 196 | |
Rodriguez-Hart et al 31 | 4 (3.6) | 0 | 0 | 108 (96.4) | 112 | Of all women tested, four were positive for concurrent infections only. There are no data reported on history of AI. | |||||
Sethupathi et al 32 | 19 (12.2) | 3 (1.9) | 1 (0.6) | 133 (85.3) | 156 | 10 (6.3) | 72 (45.0) | 10 (6.3) | 68 (42.5) | 160 | Women considered to be at high risk were tested for rectal CT (women who had contacts with gonorrhoea-positive individuals, women with anorectal symptoms, women who had been sexually assaulted). |
van Liere et al 16 | 52 (8.0) | 21 (3.2) | 3 (0.5) | 578 (88.4) | 654 | 16 (2.4) | 187 (28.6) | 39 (6.0) | 412 (63.0) | 654 | |
van Rooijen et al 28 | 154 (9.3) | 1502 (90.7) | NA | NA | 1656 | All women reported a history of AI. |
A/E, concurrent infection among women tested for rectal CT; A/(A+B+C), concurrent infection among all women positive for CT regardless of site; A/(A+C), concurrent infection among women positive for rectal CT; F/J, women positive for rectal CT and reported AI among all women tested for rectal CT; F/(F+H), women who reported AI among all women positive for rectal CT.
AI, anal intercourse; CT, Chlamydia trachomatis; NA, not available.